ANDA 70082, held by Pharmobedient. Furosemide.
As of Nov 14, 2026, ANDA 70082 (Furosemide), held by Pharmobedient, was first approved by FDA on Oct 29, 1986, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 29, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Furosemide80MG · tablet;oral | Furosemide | Discontinued |
| Aug 1, 2016 | Supplement 28Labeling · Standard review | Approved | None posted |
| Aug 1, 2016 | Supplement 27Labeling · Standard review | Approved | None posted |
| Nov 4, 2008 | Supplement 22Labeling | Approved | None posted |
| Oct 22, 2001 | Supplement 17Manufacturing | Approved | None posted |
| Oct 22, 2001 | Supplement 16Manufacturing | Approved | None posted |
| Dec 7, 1998 | Supplement 15Manufacturing | Approved | None posted |
| Feb 5, 1998 | Supplement 14Manufacturing | Approved | None posted |
| Oct 6, 1997 | Supplement 13Labeling | Approved | None posted |
| Apr 24, 1996 | Supplement 12Labeling | Approved | None posted |
| Jan 7, 1994 | Supplement 11Manufacturing | Approved | None posted |
| Jun 15, 1993 | Supplement 10Labeling | Approved | None posted |
| Apr 13, 1993 | Supplement 8Labeling | Approved | None posted |
| May 6, 1992 | Supplement 7Labeling | Approved | None posted |
| Mar 18, 1992 | Supplement 6Labeling | Approved | None posted |
| Dec 27, 1990 | Supplement 5Labeling | Approved | None posted |
| May 3, 1990 | Supplement 4Labeling | Approved | None posted |
| Feb 16, 1990 | Supplement 2Labeling | Approved | None posted |
| Jan 31, 1990 | Supplement 3Manufacturing | Approved | None posted |
| Jun 10, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Oct 29, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters